Emd Performance Material

Rockland Immunochemicals is a global biotechnology company manufacturing leading edge research tools and cGMP grade proteins for basic, applied and clinical research in functional genomics, gene therapy and drug discovery markets. Rockland operates outside of Philadelphia. European and Asian markets are supported through a highly specialized network of key distributors. Rockland s antibodies are suited for individuals performing high throughput screening, drug discovery, diagnostic kit production and life science research. Primary antibodies include apolipoproteins, apoptosis/cell cycle, cytokines, cell signaling, enzymes, extracellular matrix, transcription factors (NFkB) and ubiquitin. Secondary antibodies are conjugated to a broad range of enzymes, fluorphors and magnetic particles.

Worthington Biochemical Corporation was established in 1947 in Freehold, N.J., for the express purpose of preparing enzymes for the growing biochemical research community. The company continued to grow for more than 20 years virtually without competition as a manufacturer of high-purity enzymes. It also expanded into the emerging fields of clinical diagnostics and blood analysis kits. By 1976, when it was acquired by Millipore Corporation, Worthington had more than 300 employees, had outgrown two facilities and had sales offices in Europe, Canada and California. In 1986, the founder s son, Charles Worthington, bought the family company back and continued working with enzymes, with an emphasis on extracting enzymes from various animal and plant tissues and microbial sources, such as bacteria, fungi and molds. Worthington's ability to consistently produce enzymes and other proteins in their natural condition is the key to the company's continuing success. Headquartered in Lakewood, N.J., Worthington has fewer than 50 employees and distributes its products to 17 countries.